Work

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

Year: 2021

Type: review

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/s41571-020-00460-2

Authors: Eryn Blass, Patrick A. Ott

Institutions: Dana-Farber Cancer Institute, Broad Institute, Brigham and Women's Hospital, Harvard University, Dana-Farber/Harvard Cancer Center, Massachusetts Institute of Technology

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Melanoma Research Alliance, Dana-Farber Cancer Institute, National Institute for Health and Care Research, Efficacy and Mechanism Evaluation Programme, National Cancer Institute

Award: Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition

OpenAlex ID: W3124720941

FWCI: 14.61

Cites: 149

Cited by: 1,031

Related to: 10